TITAN PHARMACEUTICALS INC — Director's Dealing 2014

Nov 12, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP)
CIK: 0000910267
Period of Report: 2014-11-10

Reporting Person: Akers Joseph A (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$0.45	2024-11-10	Common Stock (25000)		Direct